Titan Pharmaceuticals
TTNP
#10133
Rank
NZ$5.36 M
Marketcap
$5.87
Share price
0.89%
Change (1 day)
-32.58%
Change (1 year)

Operating Margin for Titan Pharmaceuticals (TTNP)

Operating Margin as of December 2024 (TTM): -15,681.40%

According to Titan Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -15,681.40%. At the end of 2022 the company had an Operating Margin of -17,010.00%.

Operating Margin history for Titan Pharmaceuticals from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2022-17,010.00%382.62%
2021-3,524.50%2202.08%
2020-153.10%-46.75%
2019-287.52%110.89%
2018-136.34%-97.95%
2017-6,654.42%-19622.65%
201634.09%-105.05%
2015-674.99%924.13%
2014-65.91%-171.13%
201392.65%-143.44%
2012-213.29%-42.93%
2011-373.72%451.94%
2010-67.71%-99.08%
2009-7,360.76%
2007-76,804.17%49.43%
2006-51,396.88%98.44%
2005-25,900.00%-68.66%
2004-82,648.39%169.66%
2003-30,649.44%2669.68%
2002-1,106.60%109.5%
2001-528.22%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-19.63%-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
-856.84%-94.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,054.75%-86.90%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-100.11%๐Ÿ‡บ๐Ÿ‡ธ USA
25.49%-100.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
10.04%-100.06%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.